
CVS Health is advancing Aetna's profitability turnaround, supported by stronger Health Care Benefits results, an improved MBR and operational initiatives.
CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island.
| Revenue (TTM) | $412.64B |
| Gross Profit (TTM) | $56.30B |
| EBITDA | $16.68B |
| Operating Margin | 3.86% |
| Return on Equity | 6.21% |
| Return on Assets | 2.97% |
| Revenue/Share (TTM) | $324.15 |
| Book Value | $62.37 |
| Price-to-Book | 1.56 |
| Price-to-Sales (TTM) | 0.30 |
| EV/Revenue | 0.45 |
| EV/EBITDA | 13.92 |
| Quarterly Earnings Growth (YoY) | 188.80% |
| Quarterly Revenue Growth (YoY) | 7.10% |
| Shares Outstanding | $1.28B |
| Float | $1.28B |
| % Insiders | 0.06% |
| % Institutions | 90.97% |
Volatility is currently contracting

CVS Health is advancing Aetna's profitability turnaround, supported by stronger Health Care Benefits results, an improved MBR and operational initiatives.

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Appointments can be scheduled through the CVS Health app or CVS.com and walk-ins are accepted WOONSOCKET, R.I., Sept. 3, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that updated 2026-2027 COVID-19 vaccines are now available at CVS Pharmacy® and MinuteClinic® locations for patients at no-cost with most insurance plans.

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

UnitedHealth Group's stronger six-month return, improving UnitedHealthcare and Optum results and attractive valuation make it the better buy.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

CVS Health carries strong pharmacy momentum into H2 2026, with rising prescription volume, Rite Aid gains and higher profit.

CVS Health survey finds more than 60 percent of consumers say they are likely to get a flu shot this season. Expanded testing and treatment services help make CVS Pharmacy a convenient destination for seasonal care.

Both CVS and Intel delivered real turnaround results in 2026, then both stocks got punished for very different reasons. For a retiree drawing income from a portfolio, one of those reasons matters far more than the other.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CVS and any ticker you trade — then tracks every position and per-strategy win rate.